The Global Cardiovascular Diseases Drug Market is expected to grow steadily through 2032, driven by aging populations, rising prevalence of hypertension, coronary artery disease, and heart failure, alongside innovation in anticoagulants, lipid-lowering agents, and heart-failure therapies. Key trends include combination regimens, gene/RNA-based therapies, personalized medicine, and adv... https://www.uniprismmarketresearch.com/verticals/healthcare/cardiovascular-diseases-drug